4.6 Article

Peak Bone Mass From Longitudinal Data: Implications for the Prevalence, Pathophysiology, and Diagnosis of Osteoporosis

期刊

JOURNAL OF BONE AND MINERAL RESEARCH
卷 25, 期 9, 页码 1948-1957

出版社

WILEY
DOI: 10.1002/jbmr.95

关键词

PEAK BONE MASS; T-SCORES; OSTEOPOROSIS PREVALENCE; GEOGRAPHIC VARIATION; LONGITUDINAL

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. Merck Frosst Canada, Ltd.
  3. Eli Lilly Canada, Inc.
  4. Novartis Pharmaceuticals, Inc.
  5. Alliance for Better Bone Health (Sanofi-Aventis and Procter & Gamble Pharmaceuticals Canada, Inc.)
  6. Amgen
  7. Dairy Farmers of Canada
  8. The Arthritis Society

向作者/读者索取更多资源

We estimated peak bone mass (PBM) in 615 women and 527 men aged 16 to 40 years using longitudinal data from the Canadian Multicentre Osteoporosis Study (CaMos). Individual rates of change were averaged to find the mean rate of change for each baseline age. The age range for PBM was defined as the period during which bone mineral density (BMD) was stable. PBM was estimated via hierarchical models, weighted according to 2006 Canadian Census data. Lumbar spine PBM (1.046 +/- 0.123 g/cm(2)) occurred at ages 33 to 40 years in women and at 19 to 33 years in men (1.066 +/- 0.129 g/cm(2)). Total hip PBM (0.981 +/- 0.122 g/cm(2)) occurred at ages 16 to 19 years in women and 19 to 21 years in men (1.093 +/- 0.169 g/cm(2)). Analysis of Canadian geographic variation revealed that the levels of PBM and of mean BMD in those over age 65 sometimes were discordant, suggesting that PBM and subsequent rates of bone loss may be subject to different genetic and/or environmental influences. Based on our longitudinally estimated PBM values, the estimated Canadian prevalences of osteoporosis (T-score < -2.5) were 12.0% (L-1-L-4) and 9.1% (total hip) in women aged 50 years and older and 2.9% (L-1-L-4) and 0.9% (total hip) in men aged 50 years and older. These were higher than prevalences using cross-sectional PBM data. In summary, we found that the age at which PBM is achieved varies by sex and skeletal site, and different reference values for PBM lead to different estimates of the prevalence of osteoporosis. Furthermore, lack of concordance of PBM and BMD over age 65 suggests different determinants of PBM and subsequent bone loss. (C) 2010 American Society for Bone and Mineral Research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据